United Therapeutics (UTHR) Tops Q4 EPS by 51c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
United Therapeutics Corp. (UTHR) PT Raised to $175 at Oppenheimer
February 23, 2017 9:27 AM ESTOppenheimer raised its price target on United Therapeutics Corp. (NASDAQ: UTHR) to $175.00 (from $160.00) while maintaining a Outperform rating.
Analyst Hartaj Singh commented, "United Therapeutics (UTHR) reported 4Q16 sales/earnings and provided a business update to investors earlier today. The company reported a... More
